RE: What are the signs of a company takeover31 Jul 2024 09:20
Ben from Feb this year
The multiple ascending dose study is ongoing and full safety data from the Phase 1a clinical trial are expected to be available during the first half of 2024. If the results are satisfactory and subject to financing, regulatory requirements, and recruitment preparations, the Company plans to initiate a Phase 1b clinical study. The goal is to recruit up to 24 psoriasis patients, with the study expected to be completed by the end of 2024.
Now are you saying the BOD are telling porkies
Wouldn’t be the first time just so they can keep interest
Agile the biggest load of tosh ever given out and we were never going to qualify for it unless we were still in lockdown now
1801 going into clinic this year another boast which never happened and decimated the SP
So when people wonder why I don’t have faith in Parker maybe they can cast their minds back .As discussed at the AGM there was talk of a shuffle at the top this has now happened so don’t be dissapointed if nothing else comes out of the silence apart from the data is good hopefully excellent . We still have 5 months to play with to see if the ph2 trial will materialised remember only 24 participants depending on funding
Science good , So far
Management of the company , definately not and still no engagement with shareholders unless they are wanting money
GLA still to play for and if I’m wrong about Parker I’ll be the first to admit it and apologise no problem with that